Literature DB >> 32561550

Interstitial lung disease and specialist palliative care access: a healthcare professionals survey.

Jee Whang Kim1, Sandra Olive2, Steve Jones3, Muhunthan Thillai4, Anne-Marie Russell5, Miriam J Johnson6, Andrew Wilson7,2.   

Abstract

BACKGROUND: Fibrotic interstitial lung disease is an incurable disease with poor prognosis. We aimed to understand factors affecting decisions regarding referrals to specialist palliative care services and to address barriers and facilitators to referrals from healthcare professionals' perspectives.
METHODS: A survey study of healthcare professionals, including respiratory physicians, interstitial lung disease nurse specialists, respiratory nurse specialists and palliative care physicians, was conducted using a questionnaire, entailing 17 questions.
RESULTS: Thirty-six respondents, including 15 interstitial lung disease nurse specialists completed the questionnaire. Symptom control, psychological/spiritual support, general deterioration and end-of-life care were the most common reasons for referrals to specialist palliative care services. Most respondents felt confident in addressing palliative care needs and discussing palliative care with patients. A few participants emphasised that experienced respiratory nurse specialists are well placed to provide symptom management and to ensure continuity of patient care. Participants reported that access to palliative care could be improved by increasing collaborative work between respiratory and palliative care teams.
CONCLUSIONS: Most respondents felt that enhancing access to specialist palliative care services would benefit patients. However, palliative care and respiratory care should not be considered as mutually exclusive and multidisciplinary approach is recommended. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  clinical decisions; communication; education and training; respiratory conditions

Year:  2020        PMID: 32561550     DOI: 10.1136/bmjspcare-2019-002148

Source DB:  PubMed          Journal:  BMJ Support Palliat Care        ISSN: 2045-435X            Impact factor:   3.568


  2 in total

1.  Which factors influence the quality of end-of-life care in interstitial lung disease? A systematic review with narrative synthesis.

Authors:  Evelyn Palmer; Emily Kavanagh; Shelina Visram; Anne-Marie Bourke; Ian Forrest; Catherine Exley
Journal:  Palliat Med       Date:  2021-12-17       Impact factor: 4.762

2.  The Value of the Surprise Question to Predict One-Year Mortality in Idiopathic Pulmonary Fibrosis: A Prospective Cohort Study.

Authors:  Catharina C Moor; Nelleke C Tak van Jaarsveld; Catherine Owusuaa; Jelle R Miedema; Sara Baart; Carin C D van der Rijt; Marlies S Wijsenbeek
Journal:  Respiration       Date:  2021-05-27       Impact factor: 3.580

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.